Related Experiment Videos
Does beta adrenergic blockade influence the prognostic implications of post-myocardial infarction exercise testing?
1Department of Cardiovascular Medicine, University of Birmingham, East Birmingham Hospital.
Insights
Beta blockade does not affect exercise test ability to predict cardiac events post-heart attack. Stopping beta blockers before pre-discharge exercise testing is unnecessary for acute myocardial infarction patients.
Area of Science:
- Cardiology
- Clinical Medicine
- Pharmacology
Background:
- Pre-discharge exercise testing is crucial for post-myocardial infarction (MI) patients.
- Beta blockers are standard therapy for MI patients.
- The impact of beta blockade on exercise test predictive accuracy is debated.
Purpose of the Study:
- To assess the influence of beta blockade on ST depression during pre-discharge exercise testing.
- To determine if beta blockade affects the prediction of coronary anatomy and subsequent complications.
Main Methods:
- Study included 300 post-MI patients; 125 underwent cardiac catheterization.
- Exercise testing was performed pre-discharge.
- Patients were categorized based on beta blocker use at the time of exercise testing.
Main Results:
- Exercise test sensitivity for predicting multivessel disease was higher in non-beta blocker users (95%) vs. beta blocker users (76%).
- Beta blockade did not significantly alter the test's sensitivity for predicting subsequent cardiac events (84% vs. 85%).
Conclusions:
- Pre-discharge exercise testing remains valuable for risk stratification in post-MI patients, irrespective of beta blocker use.
- It is not necessary to discontinue beta blockers before pre-discharge exercise testing in acute MI patients.
Abstract:
The influence of beta blockade on the ability of ST depression, during pre-discharge exercise testing, to predict coronary anatomy and subsequent complications was studied in 300 consecutive post-infarct patients, 125 of whom underwent cardiac catheterisation. At the time of exercise 62 patients were taking a beta blocker. The exercise test had a higher sensitivity in predicting multivessel disease in patients who were not taking beta blockers than in patients who were (95% v 76%). beta Blockade did not, however, influence the ability of the test to identify patients at risk of subsequent cardiac events (sensitivity 84% and 85% respectively). These results suggest that it is not necessary to stop treatment with beta blockers before predischarge exercise testing of patients who have had an acute myocardial infarction.